期刊文献+

Synthesis of dutasteride 被引量:1

度他雄胺的合成工艺(英文)
下载PDF
导出
摘要 Aim To synthesize dutasteride. Methods The target compound was synthesized from pregnenolol via eight steps, including esterification, oxidation, hydrolysis, then oxidative ring-opening, cyclization, reduction, oxidization and finally acylation. Results The structure of the target molecule was identified by ^1H NMR, ^13C NMR and element analysis. The overall yield was 31.5%. Conclusion The effects of different reaction conditions on the yield of product in each step have been investigated and the optimal reaction conditions have been established. 目的制备度他雄胺。方法孕烯酮醇经过酯化、氧化(沃氏反应)、水解得孕烯酮酸,再经过氧化开环、环合、还原、氧化、酰基化共八步制得目标产物。结果最终产物由核磁共振谱和元素分析进行结构鉴定。总收率为31.5%。结论探索了不同条件对各个合成中间体的产率的影响,找出合适的反应条件,使之更适于工业生产。
出处 《Journal of Chinese Pharmaceutical Sciences》 CAS 2007年第3期233-235,共3页 中国药学(英文版)
关键词 Steroid hormones Dutastefide Pregnenolol Inhibition of 5α-reductase 甾体激素 度他雄胺 孕烯酮醇 5-α还原酶抑制剂
  • 相关文献

参考文献9

  • 1Connell, J.D,Bruskewitz, R.,Walsh, P.,Andriol, G.,Lieber, M.,Holtgrewe, H.L.,Albertsen, P.,Roehrborn, C.G.,Nickel, J.C,Wang, D.Z.,Taylor, A.M.,Waldstreicher, J. N. Engl. J. Med . 1998
  • 2Xie,H.W. Tianjin Pharm . 2002
  • 3Hudson, P.B,Boake, R.,Trachtenberg, J.,Romas, N.A.,Rosenblett, S.,Naragan, P.,Geller, J.,Lieber, M.M.,Elhilali, M.,Norman, R. Urology . 1999
  • 4Chen, G.G,Liu, B.C.,Chen, Z.H.,Fang, Z.,Li, X.M.,Wei, P. Chin. J. New Drugs . 2006
  • 5Zheng, J.H,Xu, F.,Liao, Q. Chin. J. Med. Chem . 1996
  • 6Velluz, L,Nomine, G,Mathieu, J. Angew. Chem (German) . 1960
  • 7Roman, D.,Durham, N.C.,Alan, M.,Jeffrey,T.S. US 6794508 . 2004
  • 8Rasmusson, G.H,Reynolds, G.F.,Steinberg, N.G.,Walton, E.,Patel, G.F.,Liang, T.,Cascieri, M.A.,Cheung, A.H,Brooks, J.R.,Berman, C. J. Medicinal Chemistry . 1986
  • 9Kenneth, W.B.,Stephen, V.F.,George, F. Dorsey, Jr.,Robert, A.,Mook, Jr. US 5846976 . 1998

同被引文献8

  • 1BATCHELOR KW, FRYE SV, DORSEY GF, et al.Androstenone derivative: US, 5565467[P].1993-09-17.
  • 2FOLEY CL, BOTT SR, SHERGILL IS, et al.An update on the use of 5-alpha-reductase inhibitors[J].Drugs Today(Barc.2004,40(3):213-223.
  • 3FRYE SV, BRAMSON HN, HERMANN DJ, et al.Discovery and development of GG745, a potent inhibitor of both isozymes of 5α-reductase[J].Pharm Biotechnol, 1998,11:393-422.
  • 4REDDY MS.[J].SRINIVASULU G, SRINIVAS K, et al.Process for the preparation of 17β-N-[2,5-bis(trifluoromethyl)-phenyl]carbamoyl-4-aza-5-alpha-androst-1-en-3one: US.2005,:0059692-.
  • 5SUNDARAM VH, SRINLVASULU GH, MAYUR DK.Process for 3-oxo-4-aza-5-alpha-androstane-17-carboxylic acid: US, 20060046994[P].2005-08-24.
  • 6KING AO, ANDERSON RK, SHUMAN RF, et al.Iodotrimethylsilane-mediated 2-monohalogenation of 4-aza-5α-androstan-3-one Steroids[J].J Org Chem, 1993, 24(39), 3384-3386.
  • 7KING AO, ABRAMSON NL, ANDERSON K, et al.Process for iodinating or brominating the alpha-methylenic carbon of a secondary amide: EP, 0473225[P].1990-08-27.
  • 8DAVIS R, MILLAR A, STERBENZ JT.Process: WO, 0246207[P].2000-11-03.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部